📰 Amgen News
Page 80 - Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amgen. Real-time updates on events, politics, business and more.
April 12, 2024
Mutual of America Capital Management LLC cut its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 4.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 71,532 shares of the medical research company’s stock after selling 3,238 shares during the […]
April 11, 2024
Over the years, the now Michael B. Silevitch and Claire J. Duggan Center for STEM Education has provided more than 180 scholarships.
April 11, 2024
The U.S. Patent and Trademark Office has kicked off 2024 with several policymaking initiatives.
April 11, 2024
Amgen's stock isn't expensive, but the business does face some challenges, which could have investors thinking twice.
April 11, 2024
Deepak Bhatt, MD, MPH, MBA, provides a recap of top trials and new data from the American College of Cardiology's 2024 Annual Scientific Session.
April 11, 2024
See which leaders are on the move across the pharma, biotech and medical marketing industries.
April 11, 2024
Amgen's stock isn't expensive, but the business does face some challenges, which could have investors thinking twice.
April 11, 2024
Sullivan & Cromwell LLP helped Bayer defeat Merck in litigation over asbestos-containing talc liability and guided mega pharma deals such as Pfizer's $43 billion acquisition of Seagen and Amgen's $27.8 billion acquisition of Horizon Therapeutics, earning the firm a spot among Law360's 2023 Life Sciences Groups of the Year.
April 10, 2024
Stone Point Wealth LLC decreased its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,747 shares of the medical research company’s stock after selling 104 shares during the quarter. Stone Point Wealth LLC’s holdings […]
April 10, 2024
Segment Wealth Management LLC bought a new stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 793 shares of the medical research company’s stock, valued at approximately $228,000. Other hedge funds have also […]